Sichuan Huiyu Pharmaceutical Co Ltd (688553) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥58.54 Million ≈ $8.57 Million USD) by net assets (CN¥3.72 Billion ≈ $544.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sichuan Huiyu Pharmaceutical Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Sichuan Huiyu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Sichuan Huiyu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sichuan Huiyu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sichuan Huiyu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Verra Mobility Corp NASDAQ:VRRM	0.148x
Zhejiang Kanglongda Special SHG:603665	0.024x
YALLA GROUP SP.ADS/1 CL.A F:80Q	N/A
Youyou Foods Co Ltd SHG:603697	0.097x
Beijing Electronic Zone Investment and Development Group Co Ltd SHG:600658	0.024x
Noah Holdings Ltd NYSE:NOAH	0.000x
Shanghai General Healthy Information and Technology Co. Ltd. SHG:605186	0.016x
Harim Holdings Co. Ltd KQ:003380	0.055x

Annual Cash Flow Conversion Efficiency for Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 688553 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.97 Billion ≈ $581.43 Million	CN¥242.96 Million ≈ $35.55 Million	0.061x	+244.81%
2023-12-31	CN¥3.77 Billion ≈ $552.32 Million	CN¥66.93 Million ≈ $9.79 Million	0.018x	-66.02%
2022-12-31	CN¥3.72 Billion ≈ $544.07 Million	CN¥194.06 Million ≈ $28.40 Million	0.052x	-58.39%
2021-12-31	CN¥3.56 Billion ≈ $520.72 Million	CN¥446.36 Million ≈ $65.32 Million	0.125x	-75.70%
2020-12-31	CN¥751.48 Million ≈ $109.97 Million	CN¥387.95 Million ≈ $56.77 Million	0.516x	-35.33%
2019-12-31	CN¥408.65 Million ≈ $59.80 Million	CN¥326.22 Million ≈ $47.74 Million	0.798x	+193.22%
2018-12-31	CN¥-150.70 Million ≈ $-22.05 Million	CN¥129.06 Million ≈ $18.89 Million	-0.856x	-1305.63%
2017-12-31	CN¥-185.32 Million ≈ $-27.12 Million	CN¥-13.16 Million ≈ $-1.93 Million	0.071x	--

About Sichuan Huiyu Pharmaceutical Co Ltd

SHG:688553 China Drug Manufacturers - Specialty & Generic

Market Cap

$674.41 Million

CN¥4.61 Billion CNY

Market Cap Rank

#10922 Global

#3064 in China

Share Price

CN¥10.88

Change (1 day)

-0.27%

52-Week Range

CN¥10.79 - CN¥27.61

All Time High

CN¥38.07